Today: 28 June 2026
Browse Category

NASDAQ:ERAS 14 January 2026 - 6 March 2026

Tango Therapeutics stock jumps 36% after Q4 results, Erasca cancer trial pact

Tango Therapeutics stock jumps 36% after Q4 results, Erasca cancer trial pact

Tango Therapeutics shares rose 36% after announcing a collaboration with Erasca to test vopimetostat in pancreatic and lung cancers. The company reported a fourth-quarter net loss of $38.7 million and cash reserves of $343.1 million. Tango plans to start a pivotal pancreatic cancer trial in 2026 and released early efficacy data from ongoing studies.

Stock Market Today

  • M&G Emerges as a Leading FTSE 100 Dividend Stock: Five Key Reasons
    June 28, 2026, 5:41 AM EDT. M&G (LSE:MNG) has become one of the FTSE 100's top dividend stocks since its 2019 spin-off from Prudential, with annual dividend increases reflecting resilience and robust cash flows. Its dividend yield has averaged 6.3%, significantly outpacing the FTSE 100 average of 3-4%. The company's strong Solvency II capital ratio and a conservative cash-flow-to-payout ratio of 63% support a progressive and sustainable dividend policy. Despite competitive pressures from peers like Aviva and Legal & General, M&G's solid execution and brand strength underpin confidence in ongoing dividend growth. Investors are advised to consider these factors carefully before buying shares.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 28.06.2026

28 June 2026
LIVEMarkets rolling coverageStarted: June 28, 2026, 4:00 AM EDTUpdated: June 28, 2026, 5:52 AM EDT M&G Emerges as a Leading FTSE 100 Dividend Stock: Five Key Reasons June 28, 2026, 5:41 AM EDT. M&G (LSE:MNG) has become one of the FTSE 100’s top dividend stocks since its 2019 spin-off from Prudential, with annual dividend increases reflecting resilience and robust cash flows. Its dividend yield has averaged 6.3%, significantly outpacing the FTSE 100 average of 3-4%. The company’s strong Solvency II capital ratio and a conservative cash-flow-to-payout ratio of 63% support a progressive and sustainable dividend policy. Despite competitive pressures from
Go toTop